Sleep Disorders Trial, Recruiting (NCT05726890)

Sleep Disorders Trial, Recruiting NCT05726890 Sponsor: Ben-Gurion University of the Negev Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT05726890 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been diagnosed with early-childhood insomnia based on DSM-5 criteria (a standard set of diagnostic guidelines)
The parents want the child to be able to fall asleep and stay asleep without much help, and prefer to sleep separately from the child
The family has two parents and speaks Hebrew at home
The child was born after at least 36 weeks of pregnancy (not significantly premature)

Who may not be able to join:

Families where the child or either parent has a significant physical sleep condition, such as sleep apnea
Families where the child or either parent has any ongoing long-term health condition (based on what the family reports about themselves)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Liat Tikotzky, PhD, Ben-Gurion University of the Negev

Phone: +972545497243

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05726890

Sponsor: Ben-Gurion University of the Negev

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +972545497243

More information: https://clinicaltrials.gov/study/NCT05726890

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been diagnosed with early-childhood insomnia based on DSM-5 criteria (a standard set of diagnostic guidelines)
The parents want the child to be able to fall asleep and stay asleep without much help, and prefer to sleep separately from the child
The family has two parents and speaks Hebrew at home
The child was born after at least 36 weeks of pregnancy (not significantly premature)

Who may not be able to join:

Families where the child or either parent has a significant physical sleep condition, such as sleep apnea
Families where the child or either parent has any ongoing long-term health condition (based on what the family reports about themselves)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ben-Gurion University of the Negev

Registry

ClinicalTrials.gov

Start date

9 March 2023

Est. completion

30 December 2027

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Change in infant actigraphic number of night-wakings from baseline to 1-week and 2-week start of intervention; Change in parents' actigraphic number of night-wakings from baseline to 1-week and 2-week start of intervention; Change in infant actigraphic minutes awake during the night from baseline to 1-week and 2-week start of intervention; Change in parents' actigraphic minutes awake during the night from baseline to 1-week and 2-week start of intervention; Change in infant sleep logs' number of night-wakings from baseline to 1-week and 2-week start of intervention.; Change in parents' sleep l...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov